Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1Phase 1 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Myasthenia Gravis 2Strabismus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Emergence Delirium 1Autoimmune Diseases 1

Interventions

Pyridostigmine Bromide 2Prednisone 2telitacicept 1rozanolixizumab 1ravulizumab 1efgartigimod alfa 1Prednisolone 1Immunoglobulins, Intravenous 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Myasthenia Gravis × Pyridostigmine Bromide × Clear all
NCT06723548 2024-12-09

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

First Affiliated Hospital of Wenzhou Medical University

Phase 4 Not yet recruiting
30 enrolled

Autoimmune Diseases, Myasthenia Gravis

NCT03510546 2018-04-27

Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis

University of Aarhus

Phase 4 Unknown
44 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡